Document 0786 DOCN M94B0786 TI Protective effects of swainsonine against toxicity of chemotherapeutic drugs (Meeting abstract). DT 9412 AU Klein JL; George MD; Roberts JD; Kurtzberg J; Breton P; Chermann JC; Olden K; Lab of Molecular Carcinogenesis, NIEHS, Research Triangle Park,; NC 27709 SO Proc Annu Meet Am Assoc Cancer Res; 35:A1909 1994. Unique Identifier : AIDSLINE ICDB/94603595 AB Swainsonine, a plant-derived alkaloid, abrogates the cytotoxicity of drugs commonly used in cancer and AIDS therapy. In a murine bone marrow progenitor colony-forming assay, as previously published, CFU-E were more sensitive to AZT toxicity than were CFU-GM. Addition of swainsonine to the medium containing AZT increased 5-fold the number of CFU-E and CFU-GM. Similar experiments were carried out with human bone marrow. In a preliminary study, addition of 20 uM AZT to the medium decreased the number of CFU-GM colonies to 18% compared to untreated cells; the presence of 10 ug/ml of swainsonine restored the number of CFU-GM to 63% of the control. In a more extensive set of studies in a second laboratory, we used marrow from four different donors and consistently obtained an antagonistic effect of swainsonine against the AZT toxicity on CFU-GM progenitors. The protective effect of swainsonine was also observed in vivo when animals were treated with anticancer drugs such as cyclophosphamide (CPM). Swainsonine treatment (10 ug/injection, 2 injections per day) led to an almost complete protection of mice (90% survival) treated with high doses (10 mg) of CPM (50% survival with CPM alone). The same protective effect was observed when animals were treated with other drugs, such as methotrexate and doxorubicin. DE Animal Antineoplastic Agents/ANTAGONISTS & INHIB/*TOXICITY Cells, Cultured Colony-Forming Units Assay Cyclophosphamide/*TOXICITY Hematopoietic Stem Cells/CYTOLOGY/*DRUG EFFECTS Human Mice Swainsonine/*PHARMACOLOGY Zidovudine/*TOXICITY MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).